Charted: Kenvue gets a jolt

Kenvue, the maker of Tylenol, Band-Aid and Listerine spun out from Johnson and Johnson last year, is under pressure from activist investor Starboard Value, WSJ reported today.

What we're watching: While Starboard's stake in the company hasn't been disclosed, the activist's chief, Jeff Smith, is expected to disclose the campaign thesis at an industry conference tomorrow, people familiar with the matter told the paper.

• Prior to today, Kenvue shares have only gained less than 1% this year, compared to over 23% growth for the broader S&P 500.